Novavax Investor Relations https://novavax.investorroom.com/ Novavax to Participate in 2026 Jefferies Global Healthcare Conference https://novavax.investorroom.com/2026-06-01-Novavax-to-Participate-in-2026-Jefferies-Global-Healthcare-Conference Mon, 01 Jun 2026 16:00:00 -0400 https://novavax.investorroom.com/2026-06-01-Novavax-to-Participate-in-2026-Jefferies-Global-Healthcare-Conference Novavax to Participate in BofA Securities 2026 Health Care Conference https://novavax.investorroom.com/2026-05-07-Novavax-to-Participate-in-BofA-Securities-2026-Health-Care-Conference Thu, 07 May 2026 16:00:00 -0400 https://novavax.investorroom.com/2026-05-07-Novavax-to-Participate-in-BofA-Securities-2026-Health-Care-Conference Novavax Reports First Quarter 2026 Financial Results and Operational Highlights https://novavax.investorroom.com/2026-05-06-Novavax-Reports-First-Quarter-2026-Financial-Results-and-Operational-Highlights Wed, 06 May 2026 08:00:00 -0400 https://novavax.investorroom.com/2026-05-06-Novavax-Reports-First-Quarter-2026-Financial-Results-and-Operational-Highlights Novavax to Report First Quarter 2026 Financial Results on May 6, 2026 https://novavax.investorroom.com/2026-04-29-Novavax-to-Report-First-Quarter-2026-Financial-Results-on-May-6,-2026 Wed, 29 Apr 2026 16:00:00 -0400 https://novavax.investorroom.com/2026-04-29-Novavax-to-Report-First-Quarter-2026-Financial-Results-on-May-6,-2026 Nuvaxovid™ COVID-19 Vaccine Showed Better Tolerability than mNEXSPIKE in Head-to-head Sanofi-led Phase 4 Study https://novavax.investorroom.com/press-releases?item=610 Sat, 18 Apr 2026 07:00:00 -0400 https://novavax.investorroom.com/press-releases?item=610